# V1 Empirics Check — x-ai/grok-4.1-fast (Variant B)

**Model:** x-ai/grok-4.1-fast
**Variant:** B
**Date:** 2026-03-31T12:07:37.376083

---

### 1. Idea Fidelity
The paper faithfully pursues the core idea from the manifest: using concurrent open investigations (specifically, the "other-manufacturer queue" for exclusion) as an instrument for examiner bandwidth constraints at NHTSA, testing effects on recall outcomes amid fixed staffing (~90 investigators). Data sources match exactly (NHTSA flat files on investigations, 2.19M complaints, recalls), as does the exclusion restriction (other-manufacturer variation, conditional on severity/component). Key departures: (i) sample shrinks from 5,330 to 1,362 closed PE/EA investigations (2000–2024), justified implicitly by focusing on defect investigations but requiring explicit rationale; (ii) shifts from full IV chain (queue → delays → injuries) to reduced-form on recall probability/duration, dropping injury quantification despite manifest emphasis; (iii) no explicit "complaint cluster emergence" timing, but opening-date queue serves analogously. Overall, strong fidelity on identification and policy question, but misses injury cost estimation and uses smaller sample.

### 2. Summary
This paper provides causal evidence that queue congestion at NHTSA's Office of Defects Investigation reduces the probability of vehicle safety recalls, using the number of concurrent open investigations at other manufacturers as a plausibly exogenous measure of investigator workload. Each additional other-manufacturer investigation lowers recall odds by 0.14 percentage points (11% relative to mean), concentrated in early-stage Preliminary Evaluations, with supporting evidence from duration compression and severity heterogeneity. The findings quantify a "triage tax" from fixed regulatory capacity, with novel implications for auto safety enforcement and staffing.

### 3. Essential Points
1. **Sample Restrictions and Generalizability**: The analysis restricts to 1,362 closed PE/EA investigations (from ~5,330 total in manifest), excluding other types (e.g., AQ, RQ, CI) and open cases. Provide a table comparing summary statistics across full vs. restricted samples, with a formal selection equation (e.g., Heckman) or attrition tests to rule out selection biasing the queue-recall link toward high-stakes cases. Without this, coefficients may overstate effects for the broader defect queue.

2. **Identification Validity of Other-Manufacturer Queue**: While year/component FE and controls are strong, discuss potential spillovers (e.g., economy-wide shocks like recessions increasing multi-manufacturer complaints; manufacturer benchmarking where Honda learns from Ford defects). Add an event-study plot of recall probability around queue spikes from specific other-manufacturer clusters (e.g., Takata airbag waves) and a falsification test using pre-opening queue (should be zero). Current threats discussion is good but needs empirics.

3. **Missing Injury Quantification**: Manifest promised "injury cost of investigation delays," and stakes section cites 315K injuries/22K deaths, but no regression links congestion to injuries/deaths (even reduced-form). Estimate this directly (e.g., manufacturer-month injuries during investigation window on queue), or bound welfare costs using recall sizes and completion rates. Absent this, policy claims (e.g., "65 additional recalls") understate contribution to causal safety effects.

### 4. Suggestions
The paper is well-written, coherent, and leverages high-quality public data effectively, with clean reduced-form design avoiding weak IV pitfalls (F=4–83 across specs). Tables are crisp, robustness thorough (LOO, clustering), and triage mechanism convincingly documented via PE/EA split and severity heterogeneity. Standardized effects (Table A2) usefully contextualize magnitude. To elevate to AER: Insights polish:

- **Figures for Intuition**: Add 2–3 figures comprising ~30% of space. (i) Time series of total/other queue and recall rates (with 95% CI bands); (ii) binned scatterplot of other-queue (deciles) vs. recall probability, partialled-out of FE/controls; (iii) dynamic event study: average recall probability in windows ±12 months around investigation opening, interacted with queue terciles. These visualize variation (mean queue=38, SD=34.5) and parallelism assumptions.

- **Enhanced Mechanism Tests**: Build on Table 3 with interactions: queue × pre-period severity (continuous, not binary) for recall/duration; queue × investigator count (if annual staffing data available from DOT IG reports). Test if high-profile cases (e.g., dummy for top-decile pre-complaints) mute effects more. Placebo on non-safety outcomes (e.g., queue on investigation summary text length, if parsable from files).

- **Controls and Balance**: Expand Table 1 with balance tests: regress queue on observables (e.g., pre-complaints, models covered) to confirm exogeneity. Add manufacturer FE (or frequency as continuous control is good, but FE absorbs size). Interact queue with manufacturer investigation frequency to test if big firms (e.g., GM) buffer congestion better.

- **Quantification and External Validity**: Compute implied lives/injuries saved more precisely: link recalls to vehicles affected (mean 200K–500K from text), multiply by defect fatality rates (e.g., from Peltzman/Levitt lit), and back-of-envelope staffing ROI (e.g., cost of 10 investigators vs. $X million safety value). Discuss generalizability to other regulators (e.g., FDA/CDER drug reviews) with queue data. Appendix with full IV (noted weak F, but report Kleibergen-Paap for robustness).

- **Data Appendices**: Provide exact cleaning code/stata.do (link GitHub), investigation-recall match rate by year, and complaint aggregation details (manufacturer-month OK, but why not investigation-specific?). Raw concurrent queue distribution (histogram) confirms 26–76 range from manifest.

- **Literature and Framing**: Strengthen novelty by tabulating prior examiner workload papers (e.g., Kang/Heese SEC; Sampat USPTO) vs. yours (time-varying aggregate queue). Intro could cite recent NHTSA failures (e.g., 2023 Cruise robotaxi) for timeliness. JEL add D73 (bureaucracy), L62 (firm regulation).

- **Minor Polish**: Fix Table 2 typos (e.g., coefficients as -0.0014 not -0.0014 for recall; align panels). Abstract: specify "1,362 PEs/EAs." Discussion: address recall completion (e.g., 60–80% from lit?) for welfare. Word count tightens to 3,500 with figures.

These changes would make a strong AER: Insights candidate—genuine causal insight on policy capacity with policy punch. Accept with minor revisions addressing essentials.
